RNA Modifications: Current Understandings and Future Perspectives
MedComm · 2026-05 · 7 (5)
DOI: 10.1002/mco2.70734 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 19.04.2026. Verfasst von Shiyu Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Southwest Hospital Third Military Medical University (Army Medical University) Chongqing People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
RNA modification has been established as a pivotal field in epitranscriptomics, representing an emerging, dynamic, and precise regulatory layer in gene expression control. N6‐methyladenosine (m 6 A), the most prevalent internal RNA modification, is critical for post‐transcriptional regulation of RNA stability, translation, and degradation. In addition to m 6 A, RNA contains a number of other modifications that play important regulatory roles in RNA metabolism, transport, translation, and stability. Our review uses N4‐acetylcytidine (ac4C) modification as a research paradigm to conduct a systematic review of the RNA modification research framework. This article begins with RNA modifications, then discusses several RNA modification‐related regulatory enzymes before using ac4C as a detailed research example. Starting with the fundamental functions of ac4C in RNA modifications, it discusses its discovery history, the specific mechanisms of the key acetyltransferase N‐acetyltransferase 10 (NAT10) in various RNA modifications, existing detection technologies, and the functional significance of ac4C modification under physiological and pathological conditions. This review systematically explains the multidimensional roles of RNA modifications, represented by ac4C, in health and disease. We point out that RNA modification‐related regulatory enzymes, such as NAT10, can serve as prognostic biomarkers and therapeutic targets, thereby advancing disease mechanism research and improving clinical diagnosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Southwest Hospital Third Military Medical University (Army Medical University) Chongqing People's Republic of China.
- Department of Biomedical Materials Science Third Military Medical University (Army Medical University) Chongqing People's Republic of China.
- Department of Biochemistry and Molecular Biology, College of Basic Medical Science Third Military Medical University (Army Medical University) Chongqing People's Republic of China.
- Senior Department of Orthopedics The Fourth Medical Center of Chinese PLA General Hospital Beijing People's Republic of China.
- Department of Orthopedics Chinese PLA 76th Army Corps Hospital Xining People's Republic of China.
ORCID-Profile: Yueqi Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Xiao, S., Xiang, T., Yang, C., Wang, X., Huang, G., Luo, F., Xie, Z., & Chen, Y. (2026). RNA Modifications: Current Understandings and Future Perspectives. MedComm, 7(5). https://doi.org/10.1002/mco2.70734
Vancouver
Xiao S, Xiang T, Yang C, Wang X, Huang G, Luo F, et al. RNA Modifications: Current Understandings and Future Perspectives. MedComm. 2026;7(5). doi:10.1002/mco2.70734
BibTeX
@article{Xiao2026,
author = {Xiao, Shiyu and Xiang, Tingwen and Yang, Chuan and Wang, Xiaohua and Huang, Gang and Luo, Fei and Xie, Zhao and Chen, Yueqi},
title = {RNA Modifications: Current Understandings and Future Perspectives},
journal = {MedComm},
year = {2026},
volume = {7},
number = {5},
doi = {10.1002/mco2.70734}
}
EUVIMED